Active ingredientTemazepamCat. No. P-T042-001CAS 846-50-4Family · Pharmaceutical analytical standards
Temazepam
An intermediate-acting benzodiazepine used for the short-term treatment of insomnia: its usefulness as a sleeping medicine was recognised in 1969 and it came onto the market in the early 1970s. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is one of the active metabolites of diazepam: the body makes it from that molecule and, to a small extent, converts it in turn into oxazepam, another benzodiazepine.
Go to the active ingredient →Active ingredientTemazepamCat. No. P-T042-001CAS 846-50-4
Pharmacopoeial impurityTemazepam EP Impurity CCat. No. P-T042-003CAS 18818-64-9
Pharmacopoeial impurityTemazepam EP Impurity DCat. No. P-T042-004CAS 17191-70-7
Isotopically labelledTemazepam-d5Cat. No. P-T042-005CAS 136765-51-0
NitrosamineN-Nitroso Temazepam EP Impurity ACat. No. P-T042-006CAS 51145-18-7
ImpurityTemazepam Impurity 1Cat. No. P-T042-007CAS 52395-03-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceTemazepam CRSEDQM code T0040000Family TemazepamReference substanceTemazepam for id and assay CRSEDQM code Y0002417Family TemazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.